SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future
Xconomy
MARCH 1, 2019
In this Xconomy Special Report, our veteran biotech journalists Alex Lash and Ben Fidler bring you deep insights, based on conversations with key industry leaders, on what 2019 and beyond hold for biopharmaceutical companies. In this Report, you’ll learn: The key indicators that suggest a possible downturn is on the way.
Let's personalize your content